Nirsevimab: a change of paradigm in the prophylaxis of Respiratory Syncytial Virus disease among infants

Giovanni Rezza¹, Danilo Cereda², Caterina Rizzo^{3

4}, Rita Cuciniello¹, Anna Carole D'Amelio¹, Alberto Villani^{3

5

6}, Carlo Signorelli^{1

3}

Affiliations

¹ Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
² General Directorate, Regional Welfare Service, Lombardy Region, Milan, Italy.
³ National Immunization Technical Advisory Group (NITAG), Italy.
⁴ Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy.
⁵ Bambino Gesù Children's Hospital IRCCS, Hospital University Pediatrics Clinical Area, Rome, Italy.
⁶ Department of Systems Medicine, University of Rome Tor Vergata, Italy.

Free article

Giovanni Rezza et al. Ann Ig. 2025 Sep-Oct.

Free article

. 2025 Sep-Oct;37(5):684-688.

doi: 10.7416/ai.2025.2712. Epub 2025 Jun 12.

Giovanni Rezza¹, Danilo Cereda², Caterina Rizzo^{3

4}, Rita Cuciniello¹, Anna Carole D'Amelio¹, Alberto Villani^{3

5

6}, Carlo Signorelli^{1

3}

¹ Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
² General Directorate, Regional Welfare Service, Lombardy Region, Milan, Italy.
³ National Immunization Technical Advisory Group (NITAG), Italy.
⁴ Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy.
⁵ Bambino Gesù Children's Hospital IRCCS, Hospital University Pediatrics Clinical Area, Rome, Italy.
⁶ Department of Systems Medicine, University of Rome Tor Vergata, Italy.

No abstract available

Publication types